Danish drugmaker Novo Nordisk <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> said on Tuesday it will present new cardiometabolic disease data, including results from its SELECT trial, at the annual American Heart A…